Medisyn Technologies Inc.
This article was originally published in Start Up
Executive Summary
Imagine having the capability to design multiple qualified drug leads in weeks using in silico methodologies. That's what Medisyn Technologies says it is doing for itself and partners by correlating molecular topography with activity and other drug properties.